Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026)
Natera (NTRA) reported Net Income towards Common Stockholders of -$85.1 million for Q1 2026, down 27.15% on a YoY basis from -$116.8 million in Q1 2025, and down 280.09% quarter-over-quarter from $47.3 million in Q4 2025.
Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Natera has reported Net Income towards Common Stockholders for 13 years, with the latest figure at -$85.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 27.15% year-over-year to -$85.1 million; the trailing twelve-month figure through Mar 2026 stood at -$226.4 million (down 19.3% YoY), and the FY2025 full-year result was -$208.2 million, down 9.31% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$85.1 million, down from $47.3 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $47.3 million in Q4 2025, with the low at -$145.2 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$86.3 million across 5 years, with a median of -$87.5 million in 2025.
- The largest YoY upside for Net Income towards Common Stockholders was 187.96% in 2025 against a maximum downside of 177.09% in 2025.
- Natera's Net Income towards Common Stockholders stood at -$142.6 million in 2022, then soared by 45.25% to -$78.1 million in 2023, then jumped by 31.17% to -$53.7 million in 2024, then soared by 187.96% to $47.3 million in 2025, then plunged by 280.09% to -$85.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$85.1 million (Q1 2026), $47.3 million (Q4 2025), and -$87.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.11 Mn |
| Dec 31, 2025 | 47.26 Mn |
| Sep 30, 2025 | -87.54 Mn |
| Jun 30, 2025 | -100.96 Mn |
| Mar 31, 2025 | -66.94 Mn |
| Dec 31, 2024 | -53.73 Mn |
| Sep 30, 2024 | -31.59 Mn |
| Jun 30, 2024 | -37.47 Mn |
| Mar 31, 2024 | -67.60 Mn |
| Dec 31, 2023 | -78.06 Mn |
| Sep 30, 2023 | -109.03 Mn |
| Jun 30, 2023 | -110.80 Mn |
| Mar 31, 2023 | -136.94 Mn |
| Dec 31, 2022 | -142.57 Mn |
| Sep 30, 2022 | -121.48 Mn |
| Jun 30, 2022 | -145.15 Mn |
| Mar 31, 2022 | -138.60 Mn |
| Dec 31, 2021 | -140.56 Mn |
| Sep 30, 2021 | -151.27 Mn |
| Jun 30, 2021 | -116.03 Mn |